PYRIMETHAMINE AS A POTENTIAL PHARMACOLOGICAL CHAPERONE FOR LATE-ONSET FORMS OF GM2 GANGLIOSIDOSIS

समान संसाधन

• The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported
  द्वारा: Maegawa, Gustavo H. B., और अन्य
  प्रकाशित: (2006)
• An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)
  द्वारा: Clarke, Joe T.R., और अन्य
  प्रकाशित: (2010)
• Crystal Structure of β-Hexosaminidase B in Complex with Pyrimethamine, a Potential Pharmacological Chaperone()
  द्वारा: Bateman, Katherine S., और अन्य
  प्रकाशित: (2011)
• Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy
  द्वारा: Rigat, Brigitte A., और अन्य
  प्रकाशित: (2012)
• Lending a helping hand, screening chemical libraries for compounds that enhance β-hexosaminidase A activity in GM2 gangliosidosis cells
  द्वारा: Tropak, Michael B., और अन्य
  प्रकाशित: (2007)